Octagon Capital Advisors LP Avidity Biosciences, Inc. Transaction History

Octagon Capital Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $880,644 - $1.47 Million	57,371 Added 17.67%	382,000 $5.86 Million
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $30,059 - $67,708	2,988 Added 0.93%	324,629 $7.2 Million
Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $1.78 Million - $2.97 Million	-125,000 Reduced 27.99%	321,641 $5.94 Million
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $336,648 - $467,290	16,600 Added 3.86%	446,641 $9.74 Million
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $10.6 Million - $15.1 Million	430,041 New	430,041 $11 Million

256

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.28B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Octagon Capital Advisors LP with notifications on news.